- £236.59m
- £233.09m
- £182.71m
- 93
- 50
- 87
- 92
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 121 | 131 | 143 | 138 | 183 |
Cost of Revenue | |||||
Gross Profit | 43 | 51 | 53.4 | 56.6 | 64.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 115 | 120 | 136 | 127 | 167 |
Operating Profit | 5.94 | 10.7 | 7.81 | 11.1 | 15.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.67 | 9.98 | 7.06 | 10.2 | 13.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.09 | 9.68 | 5.5 | 8.69 | 11.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.45 | 9.56 | 5.46 | 9.2 | 11.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 5.45 | 9.56 | 5.46 | 9.2 | 11.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.165 | 0.214 | 0.127 | 0.239 | 0.279 |
Dividends per Share |